Screener
Revvity RVTY Life Sciences — Segment Selling, general and administrative expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept revv:SegmentSellingGeneralAndAdministrativeExpenses.
The source filing: Revvity’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000031791-26-000019
| Line item | April 5, 2026 / Life Sciences | April 5, 2026 / Diagnostics | April 5, 2026 / Total | March 30, 2025 / Life Sciences | March 30, 2025 / Diagnostics | March 30, 2025 / Total |
|---|---|---|---|---|---|---|
| Segment revenue | $361,845 | $349,273 | $711,118 | $340,395 | $324,367 | $664,762 |
| Segment cost of revenue | 131,574 | 156,753 | 119,321 | 135,190 | ||
| Segment selling, general and administrative expenses | 94,668 | 90,192 | 87,094 | 89,891 | ||
| Segment research and development expenses | 31,624 | 26,206 | 28,269 | 25,271 | ||
| Segment operating income | $103,979 | $76,122 | 180,101 | $105,711 | $74,015 | 179,726 |
| Corporate expenses | (12,247) | (9,815) | ||||
| Amortization of intangible assets | (85,081) | (82,700) | ||||
| Purchase accounting adjustments | (141) | 177 |
Item 1.Unaudited Financial Statements
FAQ
- What is Revvity's life sciences — segment selling, general and administrative expenses?
- Revvity (RVTY) reported life sciences — segment selling, general and administrative expenses of $94.67M in Q1 2026.
- How has Revvity's life sciences — segment selling, general and administrative expenses changed year-over-year?
- Revvity's life sciences — segment selling, general and administrative expenses increased by 8.7% year-over-year, from $87.09M to $94.67M.
- What is the long-term trend for Revvity's life sciences — segment selling, general and administrative expenses?
- Over 3 years (2022 to 2025), Revvity's life sciences — segment selling, general and administrative expenses has grown at a 6.8% compound annual growth rate (CAGR), from $282.98M to $344.52M.
- What does life sciences — segment selling, general and administrative expenses mean?
- Operating expenses incurred by the Life Sciences segment for sales, marketing, and general corporate administration. These costs support the commercial infrastructure and management of the business unit.
Ask your AI about Revvity's life sciences — segment selling, general and administrative expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude